Type 2 diabetes mellitus (T2DM) is typically characterized by a gradual decline in -cell function, often rooted in insulin resistance (6)
In Phase 3 TRIUMPH-1 data, nausea was reported in 28.6% of participants taking 4 mg, 38.4% taking 9 mg, and 42.4% taking 12 mg, compared with 14.8% of participants receiving placebo
It is well assessed that the CAC catalyzes the entry of acylcarnitines into the mitochondrial matrix in exchange for free carnitine (Figure 3 and Table 1)
Per-unit costs came down, but utilization rose faster, partly because new oral options attracted people who had not tried injectables
Participants received once-weekly injections of retatrutide at either the 9mg or 12mg dose, or a placebo, over 68 weeks
Compare this to peptides like GHK-Cu or TB-500 , which may require more frequent dosing due to shorter half-lives